ArticlePloS one2025
Triple-band highly sensitive terahertz metamaterial absorber for biomedical sensing applications.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Terahertz Metasurface with Four-Degree-of-Freedom Geometric Encoding for Broadband Multichannel Fingerprint Sensing.Nanomaterials (Basel, Switzerland) · 2026Article
- Machine learning-enhanced multi-band metamaterial sensor for early detection of neurological disorders.Scientific reports · 2026Article
- Article
- Machine learning-assisted optimization of a terahertz photonic metamaterial absorber for blood cancer detection.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to the growing interest in metamaterials for biomedical applications, this study presents the design and analysis of a novel, compact, triple-band metamaterial absorber for biological sensing in the terahertz range. The structure, with dimensions of 41 × 41 μm2, exhibits exceptionally high absorption rates above 99% at three distinct resonance frequencies of 1.85, 3.62, and 5.63 THz. To validate the design, an equivalent circuit model was created and evaluated alongside electric field, magnetic field, and surface current distributions. A key focus of this work is the sensor's performance, evaluated by introducing a sensing layer with varying refractive indices. The absorber demonstrates outstanding sensitivity values of 1.5 THz/RIU, 1 THz/RIU, and 0.66 THz/RIU at the third, second, and first resonances, respectively, indicating highly reliable sensing performance across multiple frequency bands. Furthermore, its suitability for biochemical applications was evaluated by testing its ability to detect different samples, such as glucose, malaria, and cervical cancer cells. The absorber also demonstrates strong performance metrics, with a maximum quality factor of 39.13 and a figure of merit (FoM) of 6.95, supporting its reliability. Additionally, its suitability for microwave imaging (MWI) technology is also examined. The combination of near-perfect absorption and high sensitivity makes this compact metamaterial absorber a promising candidate for advanced biomedical sensing and diagnostic technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.